Substance Use & Drug Information News Briefs

March 13, 2025

CEU Course of the Week:

Cannabis Today



HEADLINES

U.S. Representatives Tonko and Salinas call for administration to halt reckless staffing cuts at SAMHSA


This powerful industrial chemical is being added to fentanyl found in the U.S. 


Young adults may be more vulnerable to nicotine addiction


Surprising link between cannabis use and cognitive decline uncovered after analyzing decades of data


Overdiagnosis of adult ADHD is exacerbating the stimulant shortage


How an Oregon jail is tackling opioid addiction with a holistic approach


2017 to 2022 saw rise in ED orders for buprenorphine for opioid use disorder


New insights into the cellular mechanism of action of psilocybin


Brain receptors for cannabis could be why some people are more resilient


Controversial marijuana potency bill dies in Colorado


Sharp rise In fentanyl poisoning among US children revealed in new study


NEW PAPERS AND REPORTS


Benzodiazepine Tapering: Considerations When Benzodiazepine Risks Outweigh Benefits (Free pdf download, American Society of Addiction Medicine, March 12, 2025)


Disparities in Use of Out-of-Network Mental Health and Substance Use Treatment Versus Medical or Surgical Treatment (Psychiatry Online, March 11, 2025)


Insomnia in Patients With Substance Use Disorders: Assessment and Management (Journal of Psychiatric Practice, March 10, 2025)


“It’s within your own power”: shared decision-making to support transitions to buprenorphine  


CDC Reports Nearly 24% Decline in U.S. Drug Overdose Deaths (CDC, March 6, 2025)


A Case of Ketamine-Associated Prolonged Psychosis in the Perioperative Setting: Clinical Course and Management (Psychiatrist.com, March 8, 2025)


Find more research here

 2746 Reese Avenue, 
Evanston, IL 60201
309-242-9540
Contact Us
Facebook  Twitter  Linkedin